+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multiplex Assay Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assay), Technology, Application, End-user, and Region with Growth Forecasts, 2025-2030- Product Image
Multiplex Assay Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assay), Technology, Application, End-user, and Region with Growth Forecasts, 2025-2030- Product Image
New

Multiplex Assay Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assay), Technology, Application, End-user, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5681726
Description Jump to:
The Multiplex Assay Market was valued at USD 1.81 billion in 2024, and is projected to reach USD 4.41 billion by 2030, rising at a CAGR of 17.50%. The growing prevalence of infectious diseases is boosting the usage of multiplex assays in clinical trials. For instance, according to the American Cancer Society in 2021, 1.9 million cancer cases were reported along with 6,08,570 deaths in the United States. Multiplex assay aids in the diagnosis of cancer and reduces unnecessary invasive producers. Thus, growing chronic diseases can boost the necessity of these assays and is anticipated to fuel market growth. The increasing adoption of personalized medicine in recent years is another key factor driving the growth.

Personalized medicine is a precise medicine for an individual patient to attain improved treatment options based on the body type and disease risk. These assays ensure to be highly beneficial for the comprehensive diagnosis of personalized medicines. For instance, according to an article published in the MDPI journal in 2020, multiplex immunoassay provides a complete picture of the disease and pathways involved in Rheumatoid Arthritis (RA) and simultaneously analyzes multiple proteins that can yield biomarker signatures of RA subtypes to enable patients to benefit from personalized medicine. During the COVID-19 pandemic, multiplex testing continued to be an essential tool for healthcare professionals in effectively managing the spread of COVID-19. In addition, recently, several private companies have also developed novel versions of multiplex assays.

For instance, in Sept 2020, LabCorp launched an at-home collection version for diagnosis of influenza A/B, COVID-19, and respiratory syncytial virus single-panel tests. Furthermore, the advantages of multiplex assay over singleplex and traditional assay can boost the industry growth in coming years. Several benefits offered by these automated tests include microsampling capability, numerous arrays measured in a single trial, quicker results, high operational efficiency, easy operations, and reduced labor expenses. Thus, the industry has witnessed incremental growth in 2021 and is anticipated to have a similar trend during the forecast period. Moreover, increasing validation of the biomarkers in molecular & protein diagnostics and the rising need for high-throughput and automated systems are expected to create lucrative opportunities during the forecast period.

Multiple biomarker analysis has a wide range of applications in the area of infectious diseases, neurodegenerative diseases, autoimmune diseases, and cancer. Numerous biomarkers are being discovered, and there is a high possibility of the development of novel diagnostics. For instance, Cipla launched RT Direct multiplex PCR kit that delivers quicker results for COVID-19. Such developments can increase the market penetration of multiplex assay during the forecast period. The technological advancements and automation in the multiplex assay, improve the efficiency and speed of delivering accurate results. For instance, in July 2020, Luminex provided xMAP the INTELLIFLEX system to discover novel applications, including the exclusive ability to detect multiple antibodies in a single serology test.

In May 2022, Vela Diagnostics launched a highly automated multiplex PCR-based test for detecting antimicrobial resistance genes and UTI pathogens. Hence novel technological developments can fuel the industry growth in the near future. However, the high cost of equipment can restrict the usage of multiplex assays by researchers and manufacturers in mid and low-income countries. Also, the quality control standards and regulations are more stringent for multiplex assay compared to singlex assay, which can impede the industry growth during the forecast period.

Multiplex Assay Market Report Highlights

  • By product, the consumables segment held the dominant share in 2024. This is due to the recurring purchase of consumables along with the rise in the number of diagnostic tests.
  • The protein multiplex assay type segment dominated the industry in 2024 due to the increasing focus on proteomics studies for biomarker research and clinical diagnostics.
  • The flow cytometry technology segment held a larger share in 2024. Constant efforts by various companies to launch novel and technological advanced flow cytometer is the key factor driving the segment.
  • The research & development application segment held the largest share in 2024 due to the utilization of these assays in clinical & preclinical stages to evaluate toxicity, immunotherapy success, and drug response biomarkers.
  • The pharmaceutical & biotechnology companies end-user segment led the industry in 2024 due to a rise in pharma & biotech partnerships and collaborations to increase the multiplexing capabilities.
  • North America dominated the global industry in 2024 due to the growing R&D activities as a result of the increasing prevalence of chronic diseases.
  • Asia-Pacific is estimated to register the fastest CAGR from 2024 to 2030 due to the rising number of hospitals in emerging countries, the developing R&D sector, and the high demand for healthcare infrastructure in the region.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.12 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Market Snapshot
2.3 Segment Snapshot
2.3 Competitive Snapshot
Chapter 3 Global Multiplex Assay Market Variables, Trends, & Scope
3.1 Multiplex Assay Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Driver Analysis
3.3.1 Growing prevalence of chronic and infectious diseases
3.3.2 Significant advantages of multiplex over singleplex and traditional assays
3.3.3 Increasing applications of multiplex assays in companion diagnostics
3.3.4 Rising awareness of early diagnosis
3.4 Market Restraint Analysis
3.4.1 The high investment cost of multiplex assays
3.4.2 Stringent regulatory constraints and standards
3.5 Market Opportunity Analysis
3.5.1 Growing need for high-throughput and automated systems
3.5.2 Increasing validation of the biomarkers in protein and molecular diagnostics
3.6 Porter’s Five Forces Analysis
3.7 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Chapter 4 Multiplex Assay Market - Segment Analysis, by Product, 2018-2030 (USD Million)
4.1 Global Multiplex Assay Market: Product Movement Analysis
4.2 Consumables
4.2.1 Consumables market estimates and forecast, 2018-2030 (USD Million)
4.3 Instruments
4.3.1 Instruments market estimates and forecast, 2018-2030 (USD Million)
4.4 Software
4.4.1 Software market estimates and forecast, 2018-2030 (USD Million)
Chapter 5 Multiplex Assay Market - Segment Analysis, by Type, 2018-2030 (USD Million)
5.1 Global Multiplex Assay Market: Type Movement Analysis
5.2 Protein Multiplex Assays
5.2.1 Protein multiplex assays market estimates and forecast, 2018-2030 (USD Million)
5.2.1.1 Planar Protein Assays
5.2.1.1.1 Planar Protein Assays Market, 2018-2030 (USD Million)
5.2.1.2 Bead-Based Protein Assays
5.2.1.2.1 Bead-Based Protein Assays Market, 2018-2030 (USD Million)
5.3 Nucleic Acid Multiplex Assays
5.3.1 Nucleic Acid Multiplex Assays market estimates and forecast, 2018-2030 (USD Million)
5.3.1.1 Planar Nucleic Acid Assays
5.3.1.1.1 Planar Nucleic Acid Assays Market, 2018-2030 (USD Million)
5.3.1.2 Bead-Based Nucleic Acid Assays
5.3.1.2.1 Bead-Based Nucleic Acid Assays Market, 2018-2030 (USD Million)
5.4 Cell-Based Multiplex Assays
5.4.1 Cell-Based Multiplex Assays market estimates and forecast, 2018-2030 (USD Million)
Chapter 6 Multiplex Assay Market- Segment Analysis, by Technology, 2018-2030 (USD Million)
6.1 Multiplex Assay Market: Technology Movement Analysis
6.2 Flow Cytometry
6.2.1 Flow Cytometry market estimates and forecast, 2018-2030 (USD Million)
6.3 Fluorescence Detection
6.3.1 Fluorescence Detection market estimates and forecast, 2018-2030 (USD Million)
6.4 Luminescence
6.4.1 Luminescence market estimates and forecast, 2018-2030 (USD Million)
6.5 Multiplex Real-Time PCR
6.5.1 Multiplex Real-Time PCR market estimates and forecast, 2018-2030 (USD Million)
6.6 Other Technologies
6.6.1 Other Technologies market estimates and forecast, 2018-2030 (USD Million)
Chapter 7 Multiplex Assay Market: - Segment Analysis, by Application, 2018-2030 (USD Million)
7.1 Multiplex Assay Market: Application Movement Analysis
7.2 Research & Development
7.2.1 Research & Development market estimates and forecast, 2018-2030 (USD Million)
7.2.1.1 Drug Discovery & Development
7.2.1.1.1 Drug Discovery & Development Market, 2018-2030 (USD Million)
7.2.1.2 Biomarker Discovery & Validation
7.2.1.2.1 Biomarker Discovery & Validation Market, 2018-2030 (USD Million)
7.3 Clinical Diagnostics
7.3.1 Clinical Diagnostics market estimates and forecast, 2018-2030 (USD Million)
7.3.1.1 Infectious Diseases
7.3.1.1.1 Infectious Diseases Market, 2018-2030 (USD Million)
7.3.1.2 Cancer
7.3.1.2.1 Cancer Market, 2018-2030 (USD Million)
7.3.1.3 Cardiovascular Diseases
7.3.1.3.1 Cardiovascular Diseases Market, 2018-2030 (USD Million)
7.3.1.4 Autoimmune Diseases
7.3.1.4.1 Autoimmune Diseases Market, 2018-2030 (USD Million)
7.3.1.5 Nervous System Disorders
7.3.1.5.1 Nervous System Disorders Market, 2018-2030 (USD Million)
7.3.1.6 Metabolism & Endocrinology Disorders
7.3.1.6.1 Metabolism & Endocrinology Disorders Market, 2018-2030 (USD Million)
7.3.1.7 Other Diseases
7.3.1.7.1 Other Diseases Market, 2018-2030 (USD Million)
Chapter 8 Multiplex Assay Market: - Segment Analysis, by End User, 2018-2030 (USD Million)
8.1 Multiplex Assay Market: End User Movement Analysis
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Pharmaceutical & Biotechnology Companies market estimates and forecast, 2018-2030 (USD Million)
8.3 Hospitals & Diagnostic laboratories
8.3.1 Hospitals & Diagnostic laboratories market estimates and forecast, 2018-2030 (USD Million)
8.4 Research & Academic Institutes
8.4.1 Research & Academic Institutes market estimates and forecast, 2018-2030 (USD Million)
8.5 Other End Users
8.5.1 Other End Users market estimates and forecast, 2018-2030 (USD Million)
Chapter 9 Multiplex Assay Market: - Segment Analysis, by Region, 2018-2030 (USD Million)
9.1 Multiplex Assay Market: Regional Movement Analysis
9.2 North America
9.2.1 North America market estimates and forecast, 2018-2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 Competitive Scenario
9.2.2.3 Prevalence Insights
9.2.2.4 Regulatory Framework
9.2.2.5 Reimbursement Structure
9.2.2.6 U.S. Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Competitive Scenario
9.2.3.3 Prevalence Insights
9.2.3.4 Regulatory Framework
9.2.3.5 Reimbursement Structure
9.2.3.6 Canada Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.3 Mexico
9.3.3.1 Key Country Dynamics
9.3.3.2 Competitive Scenario
9.3.3.3 Prevalence Insights
9.3.3.4 Regulatory Framework
9.3.3.5 Reimbursement Structure
9.3.3.6 Mexico Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.3 Europe
9.3.1 Europe market estimates and forecast, 2018-2030 (USD Million)
9.3.2 UK
9.3.2.1 Key Country Dynamics
9.3.2.2 Competitive Scenario
9.3.2.3 Prevalence Insights
9.3.2.4 Regulatory Framework
9.3.2.5 Reimbursement Structure
9.3.2.6 UK Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.3.3. Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Competitive Scenario
9.3.3.3 Prevalence Insights
9.3.3.4 Regulatory Framework
9.3.3.5 Reimbursement Structure
9.3.3.6 Germany Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.3.4 Spain
9.3.4.1 Key Country Dynamics
9.3.4.2 Competitive Scenario
9.3.4.3 Prevalence Insights
9.3.4.4 Regulatory Framework
9.3.4.5 Reimbursement Structure
9.3.4.6 Spain Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.3.5 France
9.3.5.1 Key Country Dynamics
9.3.5.2 Competitive Scenario
9.3.5.3 Prevalence Insights
9.3.5.4 Regulatory Framework
9.3.5.5 Reimbursement Structure
9.3.5.6 France Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.3.6 Italy
9.3.6.1 Key Country Dynamics
9.3.6.2 Competitive Scenario
9.3.6.3 Prevalence Insights
9.3.6.4 Regulatory Framework
9.3.6.5 Reimbursement Structure
9.3.6.6 Italy Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.3.7 Denmark
9.3.7.1 Key Country Dynamics
9.3.7.2 Competitive Scenario
9.3.7.3 Prevalence Insights
9.3.7.4 Regulatory Framework
9.3.7.5 Reimbursement Structure
9.3.7.6 Denmark Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Competitive Scenario
9.3.8.3 Prevalence Insights
9.3.8.4 Regulatory Framework
9.3.8.5 Reimbursement Structure
9.3.8.6 Sweden Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Competitive Scenario
9.3.9.3 Prevalence Insights
9.3.9.4 Regulatory Framework
9.3.9.5 Reimbursement Structure
9.3.9.6 Norway Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific market estimates and forecast, 2018-2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Competitive Scenario
9.4.2.3 Prevalence Insights
9.4.2.4 Regulatory Framework
9.4.2.5 Reimbursement Structure
9.4.2.6 Japan Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 Competitive Scenario
9.4.3.3 Prevalence Insights
9.4.3.4 Regulatory Framework
9.4.3.5 Reimbursement Structure
9.4.3.6 China Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 Competitive Scenario
9.4.4.3 Prevalence Insights
9.4.4.4 Regulatory Framework
9.4.4.5 Reimbursement Structure
9.4.4.6 India Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.4.5 South Korea
9.4.5.1 Key Country Dynamics
9.4.5.2 Competitive Scenario
9.4.5.3 Prevalence Insights
9.4.5.4 Regulatory Framework
9.4.5.5 Reimbursement Structure
9.4.5.6 South Korea Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.4.6 Australia
9.4.6.1 Key Country Dynamics
9.4.6.2 Competitive Scenario
9.4.6.3 Prevalence Insights
9.4.6.4 Regulatory Framework
9.4.6.5 Reimbursement Structure
9.4.6.6 Australia Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.4.7 Thailand
9.4.7.1 Key Country Dynamics
9.4.7.2 Competitive Scenario
9.4.7.3 Prevalence Insights
9.4.7.4 Regulatory Framework
9.4.7.5 Reimbursement Structure
9.4.7.6 Thailand Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5 Latin America
9.5.1 Latin America market estimates and forecast, 2018-2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Competitive Scenario
9.5.2.3 Prevalence Insights
9.5.2.4 Regulatory Framework
9.5.2.5 Reimbursement Structure
9.5.2.6 Brazil Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.5.3 Argentina
9.5.3.1 Key Country Dynamics
9.5.3.2 Competitive Scenario
9.5.3.3 Prevalence Insights
9.5.3.4 Regulatory Framework
9.5.3.5 Reimbursement Structure
9.5.3.6 Argentina Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6 Middle East & Africa (MEA)
9.6.1 Middle East & Africa market estimates and forecast, 2018-2030 (USD Million)
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 Competitive Scenario
9.6.2.3 Prevalence Insights
9.6.2.4 Regulatory Framework
9.6.2.5 Reimbursement Structure
9.6.2.6 South Africa Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Competitive Scenario
9.6.3.3 Prevalence Insights
9.6.3.4 Regulatory Framework
9.6.3.5 Reimbursement Structure
9.6.3.6 Saudi Arabia Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 Competitive Scenario
9.6.4.3 Prevalence Insights
9.6.4.4 Regulatory Framework
9.6.4.5 Reimbursement Structure
9.6.4.6 UAE Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
9.6.5 Kuwait
9.6.5.1 Key Country Dynamics
9.6.5.2 Competitive Scenario
9.6.5.3 Prevalence Insights
9.6.5.4 Regulatory Framework
9.6.5.5 Reimbursement Structure
9.6.5.6 Kuwait Multiplex Assay Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Participant’s overview
10.2 Company/Competition Categorization
10.3 Vendor Landscape
10.3.1 BIO-RAD LABORATORIES, INC.
10.3.1.1 Company overview
10.3.1.2 Financial performance
10.3.1.3 Services benchmarking
10.3.1.4 Strategic initiatives
10.3.2 ABCAM PLC.
10.3.2.1 Company overview
10.3.2.2 Financial performance
10.3.2.3 Services benchmarking
10.3.2.4 Strategic initiatives
10.3.3 R&D SYSTEMS, INC.
10.3.3.1 Company overview
10.3.3.2 Financial performance
10.3.3.3 Services benchmarking
10.3.3.4 Strategic initiatives
10.3.4 MERCK KGAA
10.3.4.1 Company overview
10.3.4.2 Financial performance
10.3.4.3 Services benchmarking
10.3.4.4 Strategic initiatives
10.3.5 ASSAY GENIE.
10.3.5.1 Company overview
10.3.5.2 Financial performance
10.3.5.3 Services benchmarking
10.3.5.4 Strategic initiatives
10.3.6 PROMEGA CONNECTIONS
10.3.6.1 Company overview
10.3.6.2 Financial performance
10.3.6.3 Services benchmarking
10.3.6.4 Strategic initiatives
10.3.7 QIAGEN N.V.
10.3.7.1 Company overview
10.3.7.2 Financial performance
10.3.7.3 Services benchmarking
10.3.7.4 Strategic initiatives
10.3.8 THERMO FISHER SCIENTIFIC, INC.
10.3.8.1 Company overview
10.3.8.2 Financial performance
10.3.8.3 Services benchmarking
10.3.8.4 Strategic initiatives
10.3.9 LUMINEX CORPORATION
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Services benchmarking
10.3.9.4. Strategic initiatives
10.3.10 PERKIN ELMER INC.
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Services benchmarking
10.3.10.4. Strategic initiatives
10.3.11 ADVANCED CELL DIAGNOSTICS, INC.
10.3.11.1 Company overview
10.3.11.2 Financial performance
10.3.11.3 Services benchmarking
10.3.11.4 Strategic initiatives
10.1.12 SEEGENE INC.
10.3.12.1 Company overview
10.3.12.2 Financial performance
10.3.12.3 Services benchmarking
10.3.12.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 4 Global Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 5 Global Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 6 Global Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 7 Global Multiplex Assay Market, by End User, 2018-2030 (USD Million)
Table 8 Global Multiplex Assay Market, by Region, 2018-2030 (USD Million)
Table 9 North America Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 10 North America Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 11 North America Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 12 North America Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 13 North America Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 14 North America Multiplex Assay Market, by End User, 2018-2030 (USD Million)
Table 15 U.S. Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 16 U.S. Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 17 U.S. Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 18 U.S. Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 19 U.S. Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 20 Canada Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 21 Canada Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 22 Canada Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 23 Canada Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 24 Canada Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 25 Mexico Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 26 Mexico Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 27 Mexico Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 28 Mexico Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 29 Mexico Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 30 Europe Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 31 Europe Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 32 Europe Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 33 Europe Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 34 Europe Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 35 Europe Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 36 Germany Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 37 Germany Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 38 Germany Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 39 Germany Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 40 Germany Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 41 UK Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 42 UK Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 43 UK Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 44 UK Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 45 UK Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 46 France Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 47 France Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 48 France Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 49 France Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 50 France Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 51 Italy Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 52 Italy Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 53 Italy Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 54 Italy Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 55 Italy Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 56 Spain Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 57 Spain Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 58 Spain Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 59 Spain Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 60 Spain Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 61 Denmark Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 62 Denmark Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 63 Denmark Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 64 Denmark Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 65 Denmark Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 66 Sweden Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 67 Sweden Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 68 Sweden Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 69 Sweden Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 70 Sweden Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 71 Norway Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 72 Norway Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 73 Norway Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 74 Norway Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 75 Norway Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 76 Asia Pacific Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 77 Asia Pacific Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 78 Asia Pacific Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 79 Asia Pacific Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 80 Asia Pacific Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 81 Asia Pacific Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 82 China Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 83 China Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 84 China Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 85 China Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 86 China Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 87 Japan Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 88 Japan Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 89 Japan Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 90 Japan Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 91 Japan Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 92 India Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 93 India Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 94 India Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 95 India Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 96 India Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 97 South Korea Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 98 South Korea Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 99 South Korea Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 100 South Korea Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 101 South Korea Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 102 Australia Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 103 Australia Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 104 Australia Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 105 Australia Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 106 Australia Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 107 Thailand Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 108 Thailand Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 109 Thailand Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 110 Thailand Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 111 Thailand Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 112 Latin America Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 113 Latin America Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 114 Latin America Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 115 Latin America Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 116 Latin America Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 117 Latin America Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 118 Brazil Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 119 Brazil Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 120 Brazil Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 121 Brazil Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 122 Brazil Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 123 Argentina Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 124 Argentina Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 125 Argentina Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 126 Argentina Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 127 Argentina Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 128 Middle East & Africa Multiplex Assay Market, by Country, 2018-2030 (USD Million)
Table 129 Middle East & Africa Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 130 Middle East & Africa Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 131 Middle East & Africa Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 132 Middle East & Africa Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 133 Middle East & Africa Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 134 South Africa Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 135 South Africa Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 136 South Africa Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 137 South Africa Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 138 South Africa Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 139 Saudi Arabia Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 140 Saudi Arabia Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 141 Saudi Arabia Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 142 Saudi Arabia Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 143 Saudi Arabia Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 144 UAE Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 145 UAE Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 146 UAE Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 147 UAE Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 148 UAE Multiplex Assay Market, End User, 2018-2030 (USD Million)
Table 149 Kuwait Multiplex Assay Market, by Product, 2018-2030 (USD Million)
Table 150 Kuwait Multiplex Assay Market, by Type, 2018-2030 (USD Million)
Table 151 Kuwait Multiplex Assay Market, by Technology, 2018-2030 (USD Million)
Table 152 Kuwait Multiplex Assay Market, by Application, 2018-2030 (USD Million)
Table 153 Kuwait Multiplex Assay Market, End User, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Multiplex Assays Market Segmentation
Figure 8 Market Snapshot, 2021
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 13 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Figure 14 Porter’s Five Forces Analysis
Figure 15 Market Penetration Vs Growth Prospect Mapping, 2021
Figure 16 Global Multiplex Assay Market: Products Movement Analysis
Figure 17 Global Multiplex Assay Market, for Consumables, 2018-2030 (USD Million)
Figure 18 Global Multiplex Assay Market, for Instruments, 2018-2030 (USD Million)
Figure 19 Global Multiplex Assay Market, for Software, 2018-2030 (USD Million)
Figure 20 Global Multiplex Assay Market: Type Movement Analysis
Figure 21 Global Multiplex Assay Market, for Protein Multiplex Assays, 2018-2030 (USD Million)
Figure 22 Global Multiplex Assay Market, for Planar Protein Assays, 2018-2030 (USD Million)
Figure 23 Global Multiplex Assay Market, for Bead-Based Protein Assays, 2018-2030 (USD Million)
Figure 24 Global Multiplex Assay Market, for Nucleic Acid Multiplex Assays, 2018-2030 (USD Million)
Figure 25 Global Multiplex Assay Market, for Planar Nucleic Acid Assays, 2018-2030 (USD Million)
Figure 26 Global Multiplex Assay Market, for Bead-Based Nucleic Acid Assays, 2018-2030 (USD Million)
Figure 27 Global Multiplex Assay Market, for Cell-Based Multiplex Assays, 2018-2030 (USD Million)
Figure 28 Global Multiplex Assay Market: Technology Movement Analysis
Figure 29 Global Multiplex Assay Market, for Flow Cytometry, 2018-2030 (USD Million)
Figure 30 Global Multiplex Assay Market, for Fluorescence Detection, 2018-2030 (USD Million)
Figure 31 Global Multiplex Assay Market, for Luminescence,2018-2030 (USD Million)
Figure 32 Global Multiplex Assay Market, for Multiplex Real-Time PCR, 2018-2030 (USD Million)
Figure 33 Global Multiplex Assay Market, for Other Technologies, 2018-2030 (USD Million)
Figure 34 Global Multiplex Assay Market: Application Movement Analysis
Figure 35 Global Multiplex Assay Market, for Research & Development, 2018-2030 (USD Million)
Figure 36 Global Multiplex Assay Market, for Drug Discovery & Development, 2018-2030 (USD Million)
Figure 37 Global Multiplex Assay Market, for Biomarker Discovery & Validation, 2018-2030 (USD Million)
Figure 38 Global Multiplex Assay Market, for Clinical Diagnostics, 2018-2030 (USD Million)
Figure 39 Global Multiplex Assay Market, for Infectious Diseases, 2018-2030 (USD Million)
Figure 40 Global Multiplex Assay Market, for Cancer, 2018-2030 (USD Million)
Figure 41 Global Multiplex Assay Market, for Cardiovascular Diseases, 2018-2030 (USD Million)
Figure 42 Global Multiplex Assay Market, for Autoimmune Diseases, 2018-2030 (USD Million)
Figure 43 Global Multiplex Assay Market, for Nervous System Disorders, 2018-2030 (USD Million)
Figure 44 Global Multiplex Assay Market, for Metabolism & Endocrinology Disorders, 2018-2030 (USD Million)
Figure 45 Global Multiplex Assay Market, for Other Diseases, 2018-2030 (USD Million)
Figure 46 Global Multiplex Assay Market: End User Movement Analysis
Figure 47 Global Multiplex Assay Market, for Pharmaceutical & Biotechnology Companies, 2018-2030 (USD Million)
Figure 48 Global Multiplex Assay Market, for Hospitals & Diagnostic Laboratories, 2018-2030 (USD Million)
Figure 49 Global Multiplex Assay Market, for Research & Academic Institutes, 2018-2030 (USD Million)
Figure 50 Global Multiplex Assay Market, for Other End Users, 2018-2030 (USD Million)
Figure 51 Regional Marketplace: Key Takeaways
Figure 52 Regional Outlook, 2024 & 2030
Figure 53 Global Multiplex Assay Market: Regional Movement Analysis
Figure 54 North America Multiplex Assay Market, 2018-2030 (USD Million)
Figure 55 U.S. Multiplex Assay Market, 2018-2030 (USD Million)
Figure 56 Canada Multiplex Assay Market, 2018-2030 (USD Million)
Figure 57 Mexico Multiplex Assay Market, 2018-2030 (USD Million)
Figure 58 Europe Multiplex Assay Market, 2018-2030 (USD Million)
Figure 59 Germany Multiplex Assay Market, 2018-2030 (USD Million)
Figure 60 UK Multiplex Assay Market, 2018-2030 (USD Million)
Figure 61 France Multiplex Assay Market, 2018-2030 (USD Million)
Figure 62 Italy Multiplex Assay Market, 2018-2030 (USD Million)
Figure 63 Spain Multiplex Assay Market, 2018-2030 (USD Million)
Figure 64 Denmark Multiplex Assay Market, 2018-2030 (USD Million)
Figure 65 Sweden Multiplex Assay Market, 2018-2030 (USD Million)
Figure 66 Norway Multiplex Assay Market, 2018-2030 (USD Million)
Figure 67 Asia Pacific Multiplex Assay Market, 2018-2030 (USD Million)
Figure 68 Japan Multiplex Assay Market, 2018-2030 (USD Million)
Figure 69 China Multiplex Assay Market, 2018-2030 (USD Million)
Figure 70 India Multiplex Assay Market, 2018-2030 (USD Million)
Figure 71 South Korea Multiplex Assay Market, 2018-2030 (USD Million)
Figure 72 Australia Multiplex Assay Market, 2018-2030 (USD Million)
Figure 73 Thailand Multiplex Assay Market, 2018-2030 (USD Million)
Figure 74 Latin America Multiplex Assay Market, 2018-2030 (USD Million)
Figure 75 Brazil Multiplex Assay Market, 2018-2030 (USD Million)
Figure 76 Argentina Multiplex Assay Market, 2018-2030 (USD Million)
Figure 77 Middle East and Africa Multiplex Assay Market, 2018-2030 (USD Million)
Figure 78 South Africa Multiplex Assay Market, 2018-2030 (USD Million)
Figure 79 Saudi Arabia Multiplex Assay Market, 2018-2030 (USD Million)
Figure 80 UAE Multiplex Assay Market, 2018-2030 (USD Million)
Figure 81 Kuwait Multiplex Assay Market, 2018-2030 (USD Million)

Companies Mentioned

The major companies featured in this Multiplex Assay market report include:
  • Luminex Corporation
  • Bio-Rad Laboratories, Inc.
  • Abcam plc.
  • Seegene Inc.
  • Merck KGaA
  • Assay Genie.
  • Promega Connections
  • QIAGEN N.V.
  • Thermo Fisher Scientific
  • PerkinElmer Inc.
  • Advanced Cell Diagnostics, Inc.
  • R&D Systems, Inc.

Related Topics

Related Reports

Multiplex Assays Market by Product Type, Detection Technology, End User, Application - Global Forecast to 2030 - Product Image

Multiplex Assays Market by Product Type, Detection Technology, End User, Application - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Multiplex Assays Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Type, Application, and End-user - Product Image

Multiplex Assays Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Type, Application, and End-user

  • Report
  • 115 Pages
  • Global
From
Multiplex Assays Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Multiplex Assays Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 156 Pages
  • Global
From
Multiplex Assays - Global Strategic Business Report - Product Image

Multiplex Assays - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Multiplex Assays Market Report 2025 - Product Image

Multiplex Assays Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.